Regulation of estrogen receptor-α expression by the tumor suppressor gene p53 in MCF-7 cells

Journal of Endocrinology

Volumn 180, Issue 3, 2004, Pages 497-504

  Angeloni, S V ^d   Martin, M B ^a   Garcia Morales, P ^b   Castro Galache, M D ^c   Ferragut, J A ^c   Saceda, M ^b,c  

^a GEORGETOWN UNIVERSITY   (United States)

^b HOSPITAL GENERAL UNIVERSITARIO DE ELCHE   (Spain)

^c MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN RECEPTOR ALPHA; PROTEIN P53; TUMOR SUPPRESSOR PROTEIN;

ARTICLE; CANCER CELL CULTURE; CELL STRAIN MCF 7; CONTROLLED STUDY; DELETION MUTANT; DNA BINDING; GENE EXPRESSION; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; RECEPTOR UPREGULATION; TUMOR SUPPRESSOR GENE; WILD TYPE;

BREAST NEOPLASMS; CELL LINE, TUMOR; DNA, ANTISENSE; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; ESTROGEN RECEPTOR ALPHA; FEMALE; GENE EXPRESSION REGULATION; GENES, P53; GENETIC VECTORS; HUMANS; PROMOTER REGIONS (GENETICS); RECEPTORS, ESTROGEN; RNA, MESSENGER; TRANSFECTION;

EID: 1842582876     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.0.1800497     Document Type: Article

References (25)

1. Allegra JC & Lippman ME 1980 Estrogen receptor status and the disease-free interval in breast cancer. Recent Results in Cancer Research 71 20-25.
2. Baker SJ, Markowitz S, Fearon ER, Willson JK & Vogelstein B 1990 Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249 912-915.
3. Berns EM, Klijn JG, Smid M, van Staveren IL, Look MP, van Puntten WL & Fockens JA 1996 TP53 and MYC gene alterations independently predict poor prognosis in breast cancer patients. Genes Chromosomes. Cancer 16 170-179.
4. Berns EM, Fockens JA, Vossen R, Look MP, Devilee P, Henzen-Logmans SC, van Staveren IL, van Putten WL, Inganas M, Meijer-van Gelder ME, Cornelisse C, Claassen CJ, Portengen H, Bakker B & Klijn JG 2000 Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer. Cancer Research 60 2155-2162.
5. Berthois Y, Katzenellenbogen JA & Katzenellenbogen BS 1986 phenol red in tissue culture is a weak estrogen: Implications concerning the study of estrogen-responsive cells in culture. PNAS 83 2496-2500.
6. Chomczynski P & Sacchi N 1987 Single-step method of RNA isolation by acid guanidinium thiocyanante-phenol-chloroform extraction. Analytical Biochemistry 162 156-159.
7. DeConinck EC, McPherson LA & Weigel RJ 1995 Transcriptional regulation of estrogen receptor in breast carcinomas. Molecular and Cellular Biology 15 2191-2196.
8. DeSombre ER & Jensen EV 1980 Estrophilin assays in breast cancer: Quantitative features and application to the mastectomy specimens. Cancer 46 2783-2788.
9. Hollstein M, Sidransky D, Vogelstein B & Harris CC 1991 p53 Mutations in human Cancers. Science 253 49-53.
10. Hurd C, Khattre N, Alban P, Nag K, Jhanwar SC, Dinda S & Moudgil VK 1995 Hormonal regulation of the p53 tumor suppressor protein in T47D human breast carcinoma cell line. Journal of Biological Chemistry 270 28507-28510.
11. Kern SE, Pietenpol JA, Thiagalingam S, Seymour A, Kinzler KW & Vogelstein B 1992 Oncogenic forms of p53 inhibit p53-regulated gene expression. Science 256 827-830.
12. Ludes-Meyers JH, Subler MA, Shivakumar CV, Munoz RM, Jiang P, Bigger JE, Brown DR, Deb SP & Deb S 1996 Transcriptional activation of the human epidermal growth factor receptor promoter by human p53. Molecular and Cellular Biology 16 6009-6019.
13. Martin MB, Angeloni SV, Garcia-Morales P, Sholler PF, Castro-Galache MD, Ferragut JA & Saceda M 2004 Taxol regulation of estrogen receptor-α expression in MCF-7 cells. Journal of Endocrinology 180 497-504 (see this issue).
14. Moyret-Lalle C, Duriez C, Van Kerckhove J, Gilbert C, Wang Q & Puisieux A 2001 p53 induction prevents accumulation of aberrant transcripts in cancer cells. Cancer Research 61 486-488.
15. Osborne CK, Yochmowitz MG, Knight WAI & McGuire WL 1980 The value of estrogen and progesterone receptors in the treatment of breast cancer. Cancer 46 2884-2888.
16. Paridaens R, Sylvester RJ, Ferrazzi E, Legros N, LeClercq G & Hensen JC 1980 Clinical significance of the quantitative assessment of estrogen receptors in advanced breast cancer. Cancer 46 2889-2895.
17. Saceda M, Lippman ME, Chambon P, Lindsey RK, Pongliktmongkol M, Puente M & Martin MB 1988 Regulation of the estrogen receptor in MCF-7 cells by estradiol. Molecular Endocrinology 2 1157-1162.
18. Sirvent JJ, Fortuno-Mar A, Olona M & Orti A 2001 Prognostic value of p53 protein expression and clinicopathological factors in infiltrating ductal carcinoma of the breast. A study of 192 patients. Histology and Histopathology 16 99-106.
19. Smith PD, Crossland S, Parker G, Osin P, Brooks L, Waller J, Philp E, Crompton MR, Gusterson BA, Allday MJ & Crook T 1999 Novel p53 mutants selected in BRCA-associated tumours which dissociate transformation suppression from other wild-type p53 functions. Oncogene 18 2451-2459.
20. Stoica A, Saceda M, Fakhro A, Solomon HB, Fenster BD & Martin MB 1999 Regulation of estrogen receptor-a gene expression by 1,25-dihydroxyvitamin D in MCF-7 cells. Journal of Cellular Biochemistry 75 640-651.
21. Tishler RB, Lamppu DM, Park S & Price BD 1995 Microtubule-active drugs taxol, vinblastine, and nocodazole increase the levels of transcriptionally active p53. Cancer Research 55 6021-6025.
22. Velculescu VE & El Deiry WS 1996 Biological and clinical importance of the p53 tumor suppressor gene. Clinical Chemistry 42 858-868.
23. Wang L, Wu Q, Qiu P, Mirza A, McGuirk M, Kirschmeier P, Greene JR, Wang Y, Pickett CB & Liu S 2001 Analyses of p53 target genes in the human genome by bioinformatic and microarray approaches. Journal of Biological Chemistry 276 43604-43610.
24. Yonish-Rouach E, Deguin V, Zaitchouk T, Breugnot C, Mishal Z, Jenkins JR & May E 1995 Transcriptional activation plays a role in the induction of apoptosis by transiently transfected wild-type p53. Oncogene 11 2197-2205.
25. Zhan Q, Carrier F & Fornace AJ Jr 1993 Induction of cellular p53 activity by DNA-damaging agents and growth arrest. Molecular and Cellular Biology 13 4242-4250.